Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
Saved in:
| Title: | Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer. |
|---|---|
| Authors: | Peláez-García, Alberto1,2,3, Yébenes, Laura1,2, Berjón, Alberto1,2, Angulo, Antonia4, Zamora, Pilar5,6,7, Sánchez-Méndez, José Ignacio2,6,8, Espinosa, Enrique5,6,7,9, Redondo, Andrés5,6,7, Heredia-Soto, Victoria2,3,9, Mendiola, Marta1,2,3, Feliú, Jaime5,6,7,9, Hardisson, David1,2,3,6 david.hardisson@salud.madrid.org |
| Source: | PLoS ONE. 9/8/2017, Vol. 12 Issue 9, p1-12. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
